Press Releases

Date	Title	View
12/02/08	Summary Toggle Horizon Therapeutics Announces Two Pivitol HZT-501 Phase 3 Trials Meet Primary Endpoints	Horizon Therapeutics Announces Two Pivitol HZT-501 Phase 3 Trials Meet Primary Endpoints 22.7 KB
10/09/08	Summary Toggle Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer	Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer 16.5 KB
10/01/08	Summary Toggle Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference	Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference 15.6 KB
09/19/08	Summary Toggle Horizon Therapeutics to Present at UBS Global Life Sciences Conference	Horizon Therapeutics to Present at UBS Global Life Sciences Conference 15.5 KB
07/31/08	Summary Toggle Horizon Therapeutics Announces Corporate Relocation to the Chicago Area	Horizon Therapeutics Announces Corporate Relocation to the Chicago Area 17 KB
07/24/08	Summary Toggle Horizon Therapeutics Names Timothy P. Walbert as President and CEO	Horizon Therapeutics Names Timothy P. Walbert as President and CEO 17.3 KB
01/11/08	Summary Toggle Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501	Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501 19.5 KB